Souhaitez-vous accéder aux communiqués récents ?

Baker Hughes to sell Waygate Technologies business to Hexagon in an all-cash transaction for approximately $1.45 billion, before customary closing adjustmentsThis transaction is consistent with Baker...

Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly...

WISeSat und das Weltraumkommando der Schweizer Armee schließen die Pilotphase ab und bereiten die nächste Generation der WISeSat 6U-Mission vor, geplant für November 2026 Die Pilotphase...

WISeSat et le Commandement de l’Espace des Forces armées suisses finalisent la phase pilote et préparent la mission de nouvelle génération WISeSat 6U prévue pour novembre 2026 La phase pilote valide...

WISeSat and Swiss Space Command of the Swiss Armed Forces Complete Pilot Phase and Prepare Next-Generation WISeSat 6U Mission Planned for November 2026 Pilot phase validates key technical and...

For The First Time, Producers Operate With Complete Flexibility Across Cotton, Polyester, and Blended Fabrics, Printing What They Need, When They Need It At The Highest Retail Quality Unified,...

HOLLYWOOD, Fla., April 12, 2026 (GLOBE NEWSWIRE) -- Kornit Digital Ltd. (NASDAQ: KRNT “Kornit Digital”, “Kornit”, or the “Company”), a global pioneer in sustainable, on-demand digital fashion and...

ROSH-HA'AYIN, Israel, April 12, 2026 (GLOBE NEWSWIRE) -- Kornit Digital Ltd. (“Kornit Digital”, “Kornit” or the “Company”), a global pioneer in sustainable, on-demand, digital fashion and...

BioNTech gab heute positive Ergebnisse aus der primären Analyse einer Phase-2-Kohorte mit Trastuzumab Pamirtecan bei HER2+ Gebärmutterkrebs bekannt.

BioNTech today announced positive results from the primary analysis of a Phase 2 cohort evaluating trastuzumab pamirtecan in HER2+ endometrial cancer.